Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Ocular Therapeutix Inc OCUL

Healthcare
Ocular Therapeutix, Inc. is a biopharmaceutical company. The Company is engaged in the development and commercialization of therapies for wet age-related macular degeneration (wet AMD), diabetic retinopathy, and other diseases and conditions of the eye. Its first commercial drug product, DEXTENZA, is for the treatment of ocular inflammation and pain following ophthalmic surgery and ocular... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:OCUL)

Ocular Therapeutix(TM) Reports Third Quarter 2024 Results and Business Highlights

GlobeNewswire 7 days ago

Ocular Therapeutix(TM) to Present at the Jefferies London Healthcare Conference and Ophthalmology Innovation Summit XIV

GlobeNewswire 8 days ago

Ocular Therapeutix(TM) Appoints Namrata Saroj, OD, as Chief Business Officer

GlobeNewswire 9 days ago

Ocular Therapeutix(TM) to Report Third Quarter 2024 Results on November 14, 2024

GlobeNewswire November 6, 2024

Ocular Therapeutix(TM) Announces Accelerated Timelines for SOL-1 Registrational Trial of AXPAXLI(TM) in Wet AMD

GlobeNewswire October 15, 2024

Ocular Therapeutix(TM) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire October 9, 2024

Ocular Therapeutix(TM) to Present at October Ophthalmology Meetings

GlobeNewswire October 9, 2024

Ocular Therapeutix(TM) to Present at the UBS Virtual Opthalmology Day 2024

GlobeNewswire September 25, 2024

Ocular Therapeutix(TM) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire September 12, 2024
View More News ››

Opinion & Analysis (NDAQ:OCUL)

Ocular Therapeutix Shares Climb More than 25% on Q4 Revenue and Phase 1 Wet AMD Clinical Data

Streetwise Reports March 5, 2020
View More Opinion ››

Bullboard Posts (NDAQ:OCUL)

Ocular Therapeutix, Inc. (NASDAQ:OCUL): Innovative Therapies

http://beyondspx.com/2024/07/31/ocular-therapeutix-inc-nasdaqocul-innovative-therapies-driving-growth-in-retinal-diseases/
MikeTester - August 2, 2024

Ocular Therapeutix(TM) Announces Late-Breaking Abstract of H

Just In: $OCUL Ocular Therapeutix(TM) Announces Late-Breaking Abstract of HELIOS Study to be Presented at 42nd ASRS Annual Scientific...
whytestocks - July 10, 2024

This Skyworks Solutions Analyst Turns Bullish; Here Are Top

NEWS: $OCUL This Skyworks Solutions Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday | BenzingaTop Wall Street analysts...
whytestocks - June 20, 2024

4 SMALL-CAP BIOTECH STOCKS FOR YOUR INVESTMENT PORTFOLIO!

$OCUL $LPTX $VYGR $MNMD   Clinical-Stage companies offer an exciting investment opportunity with massive upside potential. Most of...
AviseAnalytics - November 1, 2021

OCUL Predictions

The current release of OCUL's therapeutics and new expectations for products, as well as the average stock price, led to the upward...
BluSignals - October 3, 2018
View more Bullboard ››

Cascadia Minerals Ltd

Cascadia Minerals Ltd

Cascadia is a Canadian junior mining company focused on exploring for copper and gold in the Yukon and British Columbia ...
View More »